CG5503 IR + Morphine + Placebo
Phase 3Completed 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Bunionectomy
Conditions
Bunionectomy, Pain, Postoperative Pain, Acute Pain
Trial Timeline
Sep 1, 2007 → Feb 1, 2008
NCT ID
NCT00609466About CG5503 IR + Morphine + Placebo
CG5503 IR + Morphine + Placebo is a phase 3 stage product being developed by Johnson & Johnson for Bunionectomy. The current trial status is completed. This product is registered under clinical trial identifier NCT00609466. Target conditions include Bunionectomy, Pain, Postoperative Pain.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00609466 | Phase 3 | Completed |